Concurrent Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.1M Sell
196,768
-9,520
-5% -$2.22M 0.52% 27
2025
Q4
$42.7M Buy
206,288
+85,871
+71% +$17M 0.49% 35
2025
Q3
$22.3M Sell
120,417
-1,710
-1% -$293K 0.38% 52
2025
Q2
$18.7M Buy
122,127
+9,700
+9% +$1.49M 0.36% 55
2025
Q1
$18.6M Buy
112,427
+18,902
+20% +$2.96M 0.45% 44
2024
Q4
$13.5M Sell
93,525
-8,211
-8% -$1.27M 0.36% 58
2024
Q3
$16.5M Buy
101,736
+8,352
+9% +$1.33M 0.49% 42
2024
Q2
$13.6M Buy
93,384
+21,016
+29% +$3.13M 0.45% 49
2024
Q1
$11.4M Buy
72,368
+608
+0.8% +$96.8K 0.46% 49
2023
Q4
$11.2M Buy
+71,760
New +$11M 0.53% 45

Other funds holding JNJ

Concurrent Investment Advisors's JNJ Position: Q1 2026 in Review

Concurrent Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 4.6% in Q1 2026, selling an estimated $2.22M and leaving 196,768 shares worth $48.1M. The position accounts for 0.52% of the portfolio, ranked #27.

Concurrent Investment Advisors first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Concurrent Investment Advisors held 196,768 shares of Johnson & Johnson worth $48.1M as of Q1 2026.
  • Concurrent Investment Advisors sold 9,520 Johnson & Johnson shares in Q1 2026, an estimated $2.22M.
  • Johnson & Johnson made up 0.52% of Concurrent Investment Advisors's portfolio in Q1 2026, its #27 holding.
  • Concurrent Investment Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.